Advanced methods for the removal of acetaminophen from water

Acetaminophen: Properties, Clinical Uses and Adverse Effects

Volumn , Issue , 2012, Pages 57-106

  Carvalho, Ana P ^a   Mestre, Ana S ^a   Haro, Marta ^b   Ania, Conchi O ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO NACIONAL DEL CARBÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878695783     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (279)

1. Universal Declaration of Human Rights. In Article 25, 10 December 1948.
2. International Covenant on Economic, Social and Cultural Rights. In Article 11, 16 December 1966.
3. Principles 3 and 4 of Rio Declaration on Environment and Development. In United Nations Conference on Envirnoment and Development (UNCED): Rio de Janeiro, 1992.
4. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, (6), 1202-1211.
5. POSEIDON Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse. Contract No. EVK1-CT-2000-00047; http//www.eu-poseidon.com, 2001-2004.
6. Stackelberg, P. E.; Furlong, E. T.; Meyer, M. T.; Zaugg, S. D.; Henderson, A. K.; Reissman, D. B., Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 2004, 329, (1-3), 99-113.
7. Barceló, D., Emerging pollutants in water analysis. TrAC Trends Anal. Chem. 2003, 22, (10), xiv-xvi.
8. Klavarioti, M.; Mantzavinos, D.; Kassinos, D., Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ. Int. 2009, 35, (2), 402-417.
9. Ziylan, A.; Ince, N. H., The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non-conventional processes. J. Hazard. Mater. 2011, 187, (1-3), 24-36.
10. Federal Water Pollution Control Amendments 33 U.S.C. In P.L. 92-500, 92nd United States Congress, 1972; p 1251.
11. Water Framework Directive (2000/60/EC). In Parliament, E., Ed. OJL 327, 22 December, 2000; pp 1-73.
12. Stumm-Zollinger, E.; Fair, G. M., Biodegradation of steroid hormones. J. Water Pollut. Cont. Fed. 1965, 37, 1506-1510.
13. Hignite, C.; Azarnoff, D. L., Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluents. Life Sci. 1977, 20, 337-341.
14. Watts, C. D.; Crathorne, B.; Fielding, M.; Stell, C. P., Analysis of Organic Micropollutants in Water. Reidal Publishing Co.: Derdrecht, Germany, 1983.
15. Tabak, H. H.; Bunch, R. L., Steroid hormones as water pollutants. I. Metabolism of natural and synthetic ovulation-inhibiting hormones by microorganisms of activated sludge and primary settled sewage. Dev. Ind. Microbiol. 1970, 11, 367-376.
16. Tabak, H. H.; Bloomhuff., R. N.; Bunch, R. L., Steroid hormones as water pollutants. II. Studies on the persistence and stability of natural urinary and synthetic ovulation-inhibiting hormones in untreated and treated wastewaters. Dev. Ind. Microbiol. 1981, 22, 497-519.
17. Aherne, G. W.; Briggs, R., The relevance of the presence of certain synthetic steroids in the aquatic environment. J. Pharm. Pharmacol. 1989, 41, 735-736.
18. Aherne, G. W.; J., E.; Marks, V., The role of immunoassay in the analysis of microcontaminants in water samples. Ecotocol. Environ. Saf. 1985, 9, 79-83.
19. Bevans, H. E.; Goodbred, S. L.; Miesner, J. F.; Watkins, S. A.; Gross, T. S.; Denslow, N. D.; Schoeb, T., Synthetic organic compounds and carp endocrinology and histology in Las Vegas Wash and Las Vegas and Callville Bays Lake Mead, Nevada, 1992 and 1995. Water-Resources Investigations Report 1996, 96-4266.
20. Dresdow, C.; Routledge, E. J.; Brighty, G. C.; Sumpter, J. P.; Waldock, M., Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 1998, 32, (11), 1549-1558.
21. Jobling, S.; Noylan, M.; Tyler, C. R.; G., B.; Sumpter, J. P., Widespread sexual disruption in wild fish. Environ. Sci. Technol. 1998, 32, 2498-2506.
22. Kramer, V. J.; Miles-Richardson, S.; Pierens, S. L.; Giesy, J. P., Reproductive impairment and induction of alkaline-labile phosphate, a biomarker of estrogen exposure, in fathead minnows (Pimephales promelas) exposed to waterborne 17 beta-estradiol. Aquat. Toxicol. 1998, 40, (4), 335-360.
23. Snyder, S. A.; Villeneuve, D. L.; Snyder, E. M.; Giesy, J. P., Identification and quantification of estrogen receptor agonists in wastewater effluents. Environ. Sci. Technol. 2001, 35, (18), 3620-3625.
24. Purdom, C. E.; Hardiman, P. A.; Bye, V. J.; Eno, N. C.; Tyler, C. R.; Sumpter, J. P., Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 1994, 8, (4), 275-285.
25. Daughton, C. G., Pharmaceutical ingredients in drinking water: Overview of occurrence and significance of human exposure. In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations, American Chemical Society: 2010; Vol. 1048, pp 9-68.
26. Stan, H. J.; Heberer, T.; Linkerhägner, M., Vorkommen von Clofibrinsäure im aquatischen System-Führt die therapeutische Anwendung zu einer Belastung von Oberflächen-, Grund-und Trinkwasser? [Occurrence of clofibric acid in the aquatic system-Is their therapeutic use responsible for the loads found in surface, ground-and drinking water?]. Vom Wasser 1994, (83), 57-68.
27. Guidelines for Water Reuse. U.S. Environmental Protection Agency. In EPA/625/R-04/108 September 2004.
28. Cunningham, V. L.; Buzby, M.; Hutchinson, T.; Mastrocco, F.; Parke, N.; Roden, N., Effects of human pharmaceuticals on aquatic life: Next steps. Environ. Sci. Technol. 2006, 40, 3456-3462.
29. Calamari, D., Assessment of persistent and bioaccumulating chemicals in the aquatic environment. Toxicol. 2002, 181, 183-186.
30. Richardson, M. L.; Bowron, J. M., The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 1985, 37, 1-12.
31. Petrovic, M.; Eljarrat, E.; López de Alda, M. J.; Barceló, D., Endocrine disrupting compounds and other emerging contaminants in the environment: A survey on new monitoring strategies and occurrence data. Anal. Bional. Chem. 2004, 378, 549-562.
32. Carlsen, E.; Giwercman, A.; Keiding, N.; Skakkebaek, N. E., Evidence for decreasing quality of semen during past 50 years. Br. Med. J. 1992, 305, 609-613.
33. Daughton, C. G.; Ternes, T. A., Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 1999, 107, 907-938.
34. Ternes, T. A.; Meisenheimer, M.; McDowell, D.; Sacher, F.; Brauch, H.-J.r.; Haist-Gulde, B.; Preuss, G.; Wilme, U.; Zulei-Seibert, N., Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36, (17), 3855-3863.
35. Mompelat, S.; Le Bot, B.; Thomas, O., Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ. Int. 2009, 35, (5), 803-814.
36. Zuccato, E.; Castiglioni, S., Illicit drugs in the environment. Philos. Trans. R. Soc. A 2009, 367, 3965-3978.
37. Zuccato, E.; Castiglioni, S.; Fanelli, R., Identification of the pharmaceuticals for the human use contaminating the Italian aquatic environment. J. Hazard. Mater. 2005, 122, 205-209.
38. Monteiro, S. C.; Boxall, A. B. A., Occurrence and fate of human pharmaceuticals in the aquatic environment. In Reviews Environ. Contam. Toxicol., Whitacre, D. M., Ed. Springer: New York, 2010; Vol. 202, pp 53-154.
39. Daughton, C. G., Illicit drugs: contaminants in the environment and utility in forensic epidemiology. Rev. Environ. Contam. Toxicol. 2011, 210, 59-110.
40. Gielen, G.; Clinton, P. W.; Van den Heuvel, M. R.; Kimberley, M. O.; Greenfield, L. G., Influence of sewage and pharmaceuticals on soil microbial function. Environ. Toxicol. Chem. 2011, 30, (5), 1086-1095.
41. Murray, K. E.; Thomas, S. M.; Bodour, A. A., Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environ. Pollut. 2011, 158, (12), 3462-3471.
42. Halling-Sorensen, B.; Nors Nielsen, S.; Lanzky, P. F.; Ingerslev, F.; Holten LÜtzhoft, H. C.; Jorgensen, S. E., Occurrence, fate and effects of pharmaceutical substance in the environment-A review. Chemosphere 1998, 36, 357-393.
43. Khetan, S. K.; Collins, T. J., Human pharmaceuticals in the aquatic environment: A challenge to green chemistry. Chem. Rev. 2007, 107, 2319-2364.
44. Kemper, N., Veterinary antibiotics in the aquatic and terrestrial environment. Ecol. Indic. 2008, 8, 1-13.
45. Heberer, T., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol. Lett. 2002, 131, 5-17.
46. Krümmerer, K., Significance of antibiotics in the environment. J. Antimicrob. Chemother. 2003, 52, 5-7.
47. Hernando, M. D.; Heat, E.; Petrovic, M.; Barceló, D., Trace-level determination of pharmaceutical residues by LC-MS-MS in natural and treated waters. A pilot-survey study. Anal Bional Chem. 2006, 385, 985-991.
48. Radjenovic, J.; Petrovic, M.; Ventura, F.; Barcelo, D., Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res. 2008, 42, (14), 3601-3610.
49. Vanderford, B. J.; Snyder, S. A., Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ. Sci. Technol. 2006, 40, 7312-7320.
50. Zhao, X.; Metcalfe, C. D., Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry: Analysis of neutral pharmaceutics in wastewater. Analytical Chemistry 2008, 80, 2010-2017.
51. Ternes, T., Pharmaceuticals and metabolites as contaminants of the aquatic environment-an overview. Abstracts of Papers of ACS 2000, 219, U622-U623.
52. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N., Human pharmaceuticals in wastewater treatment processes. Crit. Rev. Environ. Sci. Technol. 2005, 35, 401-427.
53. Gomez, M. J.; Bueno, M. J. M.; Lacorte, S.; Fernandez-Alba, A. R.; Aguera, A., Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66, (6), 993-1002.
54. Zuccato, E.; Castiglioni, S.; Fanelli, R.; Reitano, G.; Bagnati, R.; Chiabrando, C.; Pomati, F.; Rossetti, C.; Calamari, D., Pharmaceuticals in the environment in Italy: Causes, occurrence, effects and control. Environ. Sci. & Pollut. Res. 2006, 13 (1), 1521.
55. Pharmaceuticals in the environment. Sources, Fate, Effects and Risks. K. Kumerer (ed.). Springer 2004.
56. Löffler, D.; Römbke, J.; Meller, M.; Ternes, T. A., Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol. 2005, 39, (14), 5209-5218.
57. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N., Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol. 2004, 34, (4), 335-350.
58. Webb, S. F., A data based perspective on the environmental risk assessment of human pharmaceuticals. III. Indirect exposure.. In Pharmaceuticals in the Environment, Kümmerer, K., Ed. Springer: Heidelberg, Germany, 2001; p 221.
59. Schwatz, T.; Kohnen, W.; Jansen, B.; Obst, U., Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMSMicrobiol. Ecol. 2003, 43, 325-335.
60. Schaiger, J.; Ferling, H.; Mallow, U.; Wintermayr, H.; Negele, R. D., Toxic effects of the non-steroidal anti-Inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicol. 2004, 68, 141-150.
61. Baquero, F.; Martínez, J. L.; Cantón, R., Antibiotics and antibiotic resistance in water environments. Curr. Opin. Biotechnol. 2008, 19, 260-265.
62. Guardabassi, L.; Dalsgaard, A.; Olsen, J. E., Phenotypic characterization and antibiotic resistance of Acinetobacter Spp. isolated from aquatic sources. J. Appl. Microbiol. 1999, 87, 659-667.
63. Muela, A.; Porcino, M.; Arana, I.; Justo, J. I.; Iriberri, J.; Barcina, I., Effect of growth phase and parental cell survival in river water on plasmid transfer between Eschericachia Coli strains. Appl. Env. Microbiol. 1994, 60, 4273-4278.
64. Carlsson, C.; Johansson, A. K.; Alvan, G.; Bergman, K.; Kühler, T., Are pharmaceuticals potent environmenal pollutants? Part I: Environmental risk assessments of selected active pharmaceutical ingredients. Sci.Total Environ. 2006, 364, 67-87.
65. Goñi-Uriza, M.; Capdepuy, M.; Arpin, C.; Raymond, N.; Pierre Caumette, C. Q., Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas Spp. Appl. Env. Microbiol. 2000, 66, 125-132.
66. di Delupis, G. D.; Macri, A.; Civitareale, A. C.; Migliore, L., Antibiotics of zootechnical use: Effects of actue high and low dose contamination on Daphnia Magna Straus. Aquat. Toxicol. 1992, 22, 53-59.
67. Pomati, F.; Netting, A. G.; Calamari, D.; Neilan, B. A., Effects of erythromycin, tetrcycline and ibuprofen on the growth of Synechocystis Sp. and Lemna Minor. Aquatic Toxicol. 2004, 67, 387-396.
68. Westergaard, K.; Müller, A. K.; Christensen, S.; Bloem, J.; Sorensen, S. J., Effects of tylosin as a disturbance on the soil microbial community. Soil Biol. Biochem. 2001, 33, 2061-2071.
69. Sommer, C.; Bibby, B. M., The influence of veterinary medicines on the decomposition of dung organic matter in soil. Eur. J. Soil Biol. 2002, 38, 155-159.
70. Contaminant Candidate List 3-CCL In United States Environmental Protection Agency: http://www.epa.gov/safewater/ccl/index.html.
71. Daughton, C. G. In Pharmaceuticals in the environment: Overarching issues and overview, Pharmaceuticals and personal care products in the environment scientific and regulatory issues, Washington, DC, 2001; Daughton, C. G.; Jones, T., Eds. Washington, DC, 2001; pp 2-38.
72. Tauxe-Wuersch, A.; De Alencastro, L. F.; Grandjean, D.; Tarradellas, J., Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 2005, 39, (9), 1761-1772.
73. Yang, X.; Flowers, R. C.; Weinberg, H. S.; Singer, P. C., Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Res. 2011, 45, (16), 5218-5228.
74. Ternes, T. A., Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, (11), 3245-3260.
75. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N., Human pharmaceuticals in the aquatic environment-A review. Environ. Technol. 2001, 22, (12), 1383-1394.
76. Jones, O. A.; Lester, J. N.; Voulvoulis, N., Pharmaceuticals: a threat to drinking water? Trends Biotechnol. 2005, 23, (4), 163-167.
77. Heberer, T., Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266, (3-4), 175-189.
78. Matamoros, V.; Arias, C.; Brix, H.; Bayona, J. M., Preliminary screening of small-scale domestic wastewater treatment systems for removal of pharmaceutical and personal care products. Water Res. 2009, 43, (1), 55-62.
79. Onesios, K. M.; Yu, J. T.; Bouwer, E. J., Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: A review. Biodegrad. 2009, 20, (4), 441-466.
80. Bruchet, A.; Hochereau, C.; Picard, C.; Decottignies, V.; Rodrigues, J. M.; Janex-Habibi, M. L., Analysis of drugs and personal care products in French source and drinking waters: The analytical challenge and examples of application. Water Sci. Technol. 2005, 52, (8), 53-61.
81. Gibs, J.; Stackelberg, P. E.; Furlong, E. T.; Meyer, M.; Zaugg, S. D.; Lippincott, R. L., Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007, 373, (1), 240-249.
82. Benotti, M. J.; Trenholm, R. A.; Vanderford, B. J.; Holady, J. C.; Stanford, B. D.; Snyder, S. A., Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 2009, 43, (3), 597-603.
83. Newcombe, G.; Dixon, D., Interface Science in Drinking Water Treatment. Academic Press: 2006.
84. Adams, C.; Wang, Y.; Loftin, K.; Meyer, M., Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng.-ASCE 2002, 128, (3), 253-260.
85. Huber, M. M.; Korhonen, S.; Ternes, T. A.; von Gunten, U., Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res. 2005, 39, (15), 3607-3617.
86. Ikehata, K.; Naghashkar, N. J.; Ei-Din, M. G., Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review. Ozone: Sci. Eng. 2006, 28, (6), 353-414.
87. Pinkston, K. E.; Sedlak, D. L., Transformation of aromatic ether-and amine-containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 2004, 38, (14), 4019-4025.
88. P-Three Project. Removal of persistent polar pollutants through improved treatment of wastewater effluent. In http://www.pthree.de/, Project Reference: EVK1-CT-2006-00116.
89. Wang, L. K.; Hung, Y. T.; Shammas, N. K., Handbook of Environmental Engineering. Human Press; 1st Ed.: 2007.
90. Opennländer, T., Photochemical purification of water and air: advanced oxidation processes (AOPs): Principles, reaction mechenisms, reactor concepts. Wiley-VCH: 2003.
91. Ernst, M.; Jekel, M., Advanced treatment combination for groundwater recharge of municipal wastewater by nanofiltration and ozonation. Water Sci. Technol. 1999, 40, 277-284.
92. Gogate, R.; Pandit, A. B., A review of imperative technologies for wastewater treatment I: oxidation technologies at ambient conditions. Adv. Environ. Res. 2004, 8, 501-551.
93. Brillas, E.; Sires, I.; Arias, C.; Cabot, P. L.; Centellas, F.; Rodriguez, R. M.; Garrido, J. A., Mineralization of paracetamol in aqueous medium by anodic oxidation with a boron-doped diamond electrode. Chemosphere 2005, 58, (4), 399-406.
94. Comninellis, C.; Kapalka, A.; Malato, S.; Parsons, S. A.; Poulios, I.; Mantzavinos, D., Advanced oxidation processes for water treatment: Advances and trends for R&D. J. Chem. Technol. Biotechnol. 2008, 83, 769-776.
95. Cambridge Crystallografic Data Center. Reciprocal Net site Software, 0.9.0-246. ; Copyright ©: 2002-2008.
96. Bosch, M. E.; Sánchez, A. J. R.; Rojas, F. S.; Ojeda, C. B., Determination of paracetamol: Historical evolution. J. Pharm. Biomed. Anal. 2006, 42, (3), 291-321.
97. Larson, A. M.; Polson, J.; Fontana, R. J.; Davern, T. J.; Lalani, E.; Hynan, L. S.; Reisch, J. S.; Schiodt, F. V.; Ostapowicz, G.; Shakil, A. O.; Lee, W. M.; Acute Liver Failure Study, G., Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005, 42, (6), 1364-1372.
98. Sheen, L.; Dillon, J. F.; Bateman, D. N.; Simpson, K. J.; Macdonald, T. M., Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. Q/M 2002, 95, 609-619.
99. Farmaco, A. I.d., Bolletino di informazione. Ministero della Salute, Roma 2005.
100. Sebastine, I. M.; Wakeman, R. J., Consumption and environmental hazards of pharmaceutical substances in the UK. Process Saf Environ. Prot. 2003, 81, (B4), 229-235.
101. Tambosi, J. L.; Yamanaka, L. Y.; Jose, H. J.; Moreira, R.; Schroder, H. F., Recent research data on the removal of pharmaceuticals from sewage treatment plants (STP) Quim. Nova 2010, 33, (2), 411-420.
102. Mirasol, F., Acetaminophen market sees moderate price hike. Chem. Mark. Rep. 1998, 254, 12.
103. Ellenhorn, M. J.; Barceloux, D. G., Medical Toxicology-Diagnosis and Treatment of Human Poisoning. Elsevier Science: New York, 1988.
104. Schomburg, D.; Salzmann, M., Handbook, Part 4. Springer-Verlag: Berlin, Heidelberg, 1991.
105. Dalmazio, I.; Alves, T. M. A.; Augusti, R., An appraisal on the degradation of paracetamol by TiO2/UV system in aqueous medium. Product identification by gas chromatography-mass spectrometry (GC-MS). J. Braz. Chem. Soc. 2008, 19, (1), 81-88.
106. 2/UV system. Water Res. 2003, 37, (5), 993-1004.
107. Bonvin, F.; Rutler, R.; Chèvre, N.; Halder, J.; Kohn, T., Spatial and temporal presence of a wastewater-derived micropollutant plume in lake Geneva. Environ. Sci.Technol. 2011, 45, (11), 4702-4709.
108. Ginebreda, A.; Muñoz, I.; López de Alda, M.; Brix, R.; López-Doval, J.; Barceló, D., Environmental risk assessment of pharmaceuticals in rivers: Relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Env. Int. 2010, 36, 153-162.
109. Wiegel, S.; Aulinger, A.; Brockmeyer, R.; Harms, H.; Löffler, J.; Reincke, H.; Schmidt, R.; Stachel, B.; von Tümpling, W.; Wanke, A., Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 2004, 57, (2), 107-126.
110. Bound, J. P.; Voulvoulis, N., Predicted and measured concentrations for selected pharmaceuticals in UK rivers: Implications for risk assessment. Water Res. 2006, 40, (15), 2885-2892.
111. Naidenko, O.; Leiba, N.; Sharp, R.; Houlihan, J., Bottled water quality investigation: 10 major brands, 38 pollutants. Bottled water contains disinfection byproducts, fertilizer residue, and pain medication. In Environmental Working Group (EWG) ed.; Washington, DC, 2009; pp 33 http://www.ewg.org/reports/bottledwater, http://www.ewg.org/node/27011.
112. Lin, A. Y.-C.; Panchangam, S. C.; Chen, H.-Y., Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: A strategic study of risk assessment. J. Environ. Monitor. 2010, 12, 261-270.
113. Brun, G. L.; Bernier, M.; Losier, R.; Doe, K.; Jackman, P.; Lee, H. B., Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 2006, 25, (8), 2163-2176.
114. Chiron, S.; Gomez, E.; Fenet, H., Nitration processes of acetaminophen in nitrifying activated sludge. Environ. Sci. Technol. 2010, 44, (1), 284-289.
115. Matsuo, H.; Sakamoto, H.; Arizono, K.; Shinohara, R., Behavior of pharmaceuticals in waste water treatment plant in Japan. Bull. Environ. Contam. Toxicol. 2011, 87, 31-35.
116. Pedrouzo, M.; Borrull, F.; Pocurull, E.; Marcé, R. M., Presence of pharmaceuticals and hormones in waters from sewage treatment plants. Water Air Soil Pollut. 2011, 217, (14), 267-281.
117. Boleda, M. R.; Galceran, M. T.; Ventura, F., Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 2011, 159, (6), 1584-1591.
118. Rosal, R.; Rodriguez, A.; Perdigon-Melon, J. A.; Petre, A.; Garcia-Calvo, E.; Gomez, M. J.; Aguera, A.; Fernandez-Alba, A. R., Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 2010, 44, (2), 578-588.
119. Han, G. H.; Hur, H. G.; Kim, S. D., Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: Occurrence and toxicity to Daphnia magna. Environ. Toxicol. Chem. 2006, 25, (1), 265-271.
120. Wennmalm, Å.; Gunnarsson, B., Pharmaceutical management through environmental product labeling in Sweden. Environ. Int. 2009, 35, (5), 775-777.
121. Morasch, B.; Bonvin, F.; Reiser, H.; Grandjean, D.; de Alencastro, L. F.; Perazzolo, C.; Chevre, N.; Kohn, T., Occurence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part II: Micropollutant removal between wastewater and raw drinking water. Environ. Toxicol. Chem. 2010, 29, (8), 1658-1668.
122. Lin, A. Y. C.; Yu, T. H.; Lin, C. F., Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere 2008, 74, (1), 131-141.
123. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N., The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ. Pollut. 2007, 145, (3), 738-744.
124. Boyd, G. R.; Reemtsma, H.; Grimm, D. A.; Mitra, S., Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 2003, 311, (1-3), 135-149.
125. Roberts, P. H.; Thomas, K. V., The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356, (1-3), 143-153.
126. Gros, M.; Petrovic, M.; Barceló, D., Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70, (4), 678-690.
127. Togola, A.; Budzinski, H., Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177, (1), 150-158.
128. Kim, S. D.; Cho, J.; Kim, I. S.; Vanderford, B. J.; Snyder, S. A., Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41, (5), 1013-1021.
129. Gómez, M. J.; Agüera, A.; Mezcua, M.; Hurtado, J.; Mocholí, F.; Fernández-Alba, A. R., Simultaneous analysis of neutral and acidic pharmaceuticals as well as related compounds by gas chromatography-tandem mass spectrometry in wastewater. Talanta 2007, 73, (2), 314-320.
130. Gómez, M. J.; Petrovic, M.; Fernandez-Alba, A. R.; Barcelo, D., Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. J. Chromatogr. A 2006, 1114, (2), 224-233.
131. Radjenovic, J.; Petrovic, M.; Barceló, D., Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal. Bioanal. Chem. 2007, 387, (4), 1365-1377.
132. Radjenovic, J.; Petrovic, M.; Barceló, D., Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43, (3), 831-841.
133. Bernabeu, A.; Vercher, R. F.; Santos-Juanes, L.; Simon, P. J.; Lardin, C.; Martinez, M. A.; Vicente, J. A.; Gonzalez, R.; Llosa, C.; Arques, A.; Amat, A. M., Solar photocatalysis as a tertiary treatment to remove emerging pollutants from wastewater treatment plant effluents. Catal. Today 2011, 161, (1), 235-240.
134. Lin, A. Y. C.; Lin, C. F.; Tsai, Y. T.; Lin, H. H. H.; Chen, J.; Wang, X. H.; Yu, T. H., Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan. Water Sci. Technol. 2010, 62, (10), 2450-2458.
135. Glassmeyer, S. T.; Furlong, E. T.; Kolpin, D. W.; Cahill, J. D.; Zaugg, S. D.; Werner, S. L.; Meyer, M. T.; Kryak, D. D., Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination. Environ. Sci. Technol. 2005, 39, (14), 5157-5169.
136. Benotti, M. J.; Brownawell, B. J., Distributions of pharmaceuticals in an urban estuary during both dry-and wet-weather conditions. Environ. Sci. Technol. 2007, 41, (16), 5795-5802.
137. Yu, J. T.; Bouwer, E. J.; Coelhan, M., Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric. Water Manag. 2006, 86, (1-2), 72-80.
138. Focazio, M. J.; Kolpin, D. W.; Barnes, K. K.; Furlong, E. T.; Meyer, M. T.; Zaugg, S. D.; Barber, L. B.; Thurman, M. E., A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States-II Untreated drinking water sources. Sci. Total Environ. 2008, 402, (2-3), 201-216.
139. Kolpin, D. W.; Skopec, M.; Meyer, M. T.; Furlong, E. T.; Zaugg, S. D., Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci. Total Environ. 2004, 328, (1-3), 119-130.
140. Stackelberg, P. E.; Gibs, J.; Furlong, E. T.; Meyer, M. T.; Zaugg, S. D.; Lippincott, R. L., Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 2007, 377, (2-3), 255-272.
141. Alvarez, D. A.; Stackelberg, P. E.; Petty, J. D.; Huckins, J. N.; Furlong, E. T.; Zaugg, S. D.; Meyer, M. T., Comparison of a novel passive sampler to standard water-column sampling for organic contaminants associated with wastewater effluents entering a New Jersey stream. Chemosphere 2005, 61, (5), 610-622.
142. Zhang, S.; Zhang, Q.; Darisaw, S.; Ehie, O.; Wang, G., Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere 2007, 66, (6), 1057-1069.
143. Barnes, K. K.; Kolpin, D. W.; Furlong, E. T.; Zaugg, S. D.; Meyer, M. T.; Barber, L. B., A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I Groundwater. Sci. Total Environ. 2008, 402, (2-3), 192-200.
144. Frick, E. A.; Henderson, A. K.; Moll, D. M.; Furlong, E. T.; Meyer, M. T. In 2001 Georgia Water Resources Conference, Athens, GA, 2001; Hatcher, K. J., Ed. Institute of Ecology, University of Georgia: Athens, GA, 2001; p 282. (cited in Ref 25).
145. Ostapowicz, G.; Fontana, R. J.; Schiodt, F. V.; Larson, A.; Davern, T. J.; Han, S. H. B.; McCashland, T. M.; Shakil, A. O.; Hay, J. E.; Hynan, L.; Crippin, J. S.; Blei, A. T.; Samuel, G.; Reisch, J.; Lee, W. M.; Grp, U. S. A. L. F. S., Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 2002, 137, (12), 947-954.
146. Lee, W. M., Acetaminophen and the US Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology 2004, 40, (1), 6-9.
147. Lee, W. M., Acetominophen Toxicity, Changing perceptions on social/medical issue. Hepatology 2007, (46), 966-970.
148. Bound, J. P.; Voulvoulis, N., Pharmaceuticals in the aquatic environment-a comparison of risk assessment strategies. Chemosphere 2004, 56, (11), 1143-1155.
149. Doc. Ref. EMEA/CHMP/SWP/4447/00) Guideline on the environmental risk assessment of medicinal products for human use. In European Medicines Agency PreAuthorisation of Medicines for Human Use Committee for medicinal products for human use (chmp): 2006.
150. Initial assessment of eleven pharmaceuticals using EMEA guideline in Norway. Department of Local Environmental Management 2006, TA-2216/20006 ISBN 82-7655295-1.
151. Schowanek, D.; Webb, S., Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER. Toxicol. Lett. 2002, 131, (1-2), 39-50.
152. Jones, O. A.; Voulvoulis, N.; Lester, J. N., Partiotioning behavior of five pharmaceutical compounds to activated sludge and river sediment. Arch. Environ. Contam. Toxicol. 2006, 50, 297-305.
153. Löffler, D.; Römbke, J.; Meller, M.; Ternes, T. A., Environmental fate of pharmaceutical compounds to activated sludge and river sediment. Env. Sci. Technol. 2005, 25, 220-225.
154. Henschel, K. P.; Wenzel, A.; Diedrich, M.; Fliedner, A., Environmental hazard assessment of pharmaceuticals. Regul. Toxicol. Pharmacol. 1997, 25, (3), 220-225.
155. IUCLID dataset paracetamol. European Commission-European Chemicals Bureau. 2000, 76.
156. Gravel, A.; Vijayan, M. M., Salicylate disrupts interrenal steroidogenesis and brain glucocoricoid receptor expression in rainbow trout. Toxicol. Sci. 2006, 93, 41-49.
157. Pascoe, D.; Karntanut, W.; Muller, C. T. M., Do pharmaceuticals affect freshwater invertebrates? A study with the Cnidarian Hydra vulgaris. Chemosphere 2003, 51, 521-528.
158. Technical guidance document in support of commission directive 93/67/EEC on risk assessment for new notified substances and commission regulation (EC) No 1488/94 on risk assessment for existing substances. In Commission of the European Communities., Office for Official Publications of the European Communities: Luxembourg, 1996.
159. Brain, R. A.; Johnson, D. J.; Richards, S. M.; Hanson, M. L.; Sanderson, H.; Lam, M. W.; Young, C.; Mabury, S. A.; Sibley, P. K.; Solomon, K. R., Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquat. Toxicol. 2004, 70, (1), 23-40.
160. Borgmann, U.; Bennie, D. T.; Ball, A. L.; Palabrica, V., Effect of a mixture of seven pharmaceuticals on Hyalella azteca over multiple generations. Chemosphere 2007, 66, 1278-1283.
161. Sanderson, H.; Johnson, D. J.; Wilson, C. J.; Brain, R. A.; Solomon, K. R., Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnias and algae by ECOSAR screening. Toxicol. Lett. 2003, 144, 383-395.
162. Parolini, M.; Binelli, A.; Cogni, D.; Riva, C.; Provini, A., An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs). Toxicol. Vitro 2009, 23, 935-942.
163. Calleja, M. C.; Persoone, G.; Geladi, P., Comparative acute toxicity of the first 50 multicenter evaluation of in-vitro cytotoxicity chemicals to aquatic non-vertebrates. Arch. Environ. Contam. Toxicol. 1994, 26, 69-78.
164. EPA, U. S., Search in Ecotoxicology Database System (U. S. EPA MED-Duluth). http://www.epa.gov/medecotx/ecotoxhome.htm 1999.
165. World Health Organization (WHO) guidelines for drinking-water quality. In World Health Organization: Geneva, 2004; p 451.
166. Miles, A. M.; Singer, P. C.; Ashley, D. L.; Lynberg, M. C.; Mendola, P.; Langlois, P. H.; Nuckols, J. R., Comparison of trihalomethanes in tap water and blood. Environ. Sci.Technol. 2002, 36, (8), 1692-1698.
167. Bedner, M.; MacCrehan, W. A., Reactions of the amine-containing drugs fluoxetine and metoprolol during chlorination and dechlorination processes used in wastewater treatment. Chemosphere 2006, 65, (11), 2130-2137.
168. Glassmeyer, S. T.; Shoemaker, J. A., Effects of chlorination on the persistence of pharmaceuticals in the environment. Bull. Environ. Contam. Toxicol. 2005, 74, (1), 2431.
169. Bedner, M.; MacCrehan, W. A., Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine. Environ. Sci. Technol. 2006, 40, (2), 516-522.
170. 2+ and UVA light. Applied Catal., B 2006, 66, (3-4), 228-240.
171. Pérez, S.; Barceló, D., First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS. Anal. Chem. 2008, 80, (21), 8135-8145.
172. Poyatos, J. M.; Munio, M. M.; Almecija, M. C.; Torres, J. C.; Hontoria, E.; Osorio, F., Advanced oxidation processes for wastewater treatment: State of the art. Water Air Soil Pollut. 2010, 205, 187-204.
173. 2 photocatalysis. Water Res. 2008, 42, (13), 3480-3488.
174. Yang, L. M.; Yu, L. E.; Ray, M. B., Photocatalytic oxidation of paracetamol: Dominant reactants, intermediates, and reaction mechanisms. Environ. Sci. Technol. 2009, 43, (2), 460-465.
175. Waterston, K.; Wang, J. W. J.; Bejan, D.; Bunce, N. J., Electrochemical waste water treatment: Electrooxidation of acetaminophen. J. Appl. Electrochem. 2006, 36, (2), 227-232.
176. Boudreau, J.; Bejan, D.; Bunce, N., Competition between electrochemical advanced oxidation and electrochemical hypochlorination of acetaminophen at boron-doped diamond and ruthenium dioxide based anodes. Can. J.Chem. 2010, 88, 418-425.
177. Sirés; Arias, C.; Cabot, P. L.; Centellas, F.; Rodriguez, R. M.; Garrido, J. A.; Brillas, E., Paracetamol mineralization by advanced electrochemical oxidation processes for wastewater treatment. Environ. Chem. 2004, 1, (1), 26-28.
178. 2+, and UVA light on electrogenerated hydrogen peroxide. J. Electrochem. Soc. 2006, 153, (1), D1-D9.
179. Almeida, L. C.; Garcia-Segura, S.; Bocchi, N.; Brillas, E., Solar photoelectro-Fenton degradation of paracetamol using a flow plant with a Pt/air-diffusion cell coupled with a compound parabolic collector: Process optimization by response surface methodology. Appl. Cat. B-Environ. 2011, 103, (1-2), 21-30.
180. 2 processes for the removal of pharmaceuticals detected in secondary effluent of a sewage treatment plant in Japan. J. Hazard. Mat. 2009, 166, (2-3), 1134-1140.
181. 2. Catal. Today 2009, 144, (12), 124-130.
182. Trovó, A. G.; Melo, S. A. S.; Nogueira, R. F. P., Photodegradation of the pharmaceuticals amoxicillin, bezafibrate and paracetamol by the photo-Fenton process-Application to sewage treatment plant effluent. J. Photochem. Photobiol., A 2008, 198, (2-3), 215-220.
183. Durán, A.; Monteagudo, J. M.; Carnicer, A.; Ruiz-Murillo, M., Photo-Fenton mineralization of synthetic municipal wastewater effluent containing acetaminophen in a pilot plant. Desalination 2011, 270, (1-3), 124-129.
184. Jordá, L. S. J.; Martín, M. M. B.; Gómez, E. O.; Reina, A. C.; Sánchez, I. M. R.; López, J. L. C.; Pérez, J. A. S., Economic evaluation of the photo-Fenton process. Mineralization level and reaction time: The keys for increasing plant efficiency. J. Hazard. Mat. 2011, 186, (2-3), 1924-1929.
185. Klamerth, N.; Malato, S.; Maldonado, M. I.; Agura, A.; Fernandez-Alba, A. R., Application of photo-Fenton as a tertiary treatment of emerging contaminants in municipal wastewater. Environ. Sci. Technol. 2010, 44, (5), 1792-1798.
186. Santos-Juanes, L.; Sanchez, J. L. G.; Lopez, J. L. C.; Oller, I.; Malato, S.; Perez, J. A. S., Dissolved oxygen concentration: A key parameter in monitoring the photo-Fenton process. Appl. Catal., B 2011, 104, (3-4), 316-323.
187. Zhang, X.; Wu, F.; Wu, X. W.; Chen, P. Y.; Deng, N. S., Photodegradation of acetaminophen in TiO2 suspended solution. J. Hazard. Mat. 2008, 157, (2-3), 300-307.
188. 2 in a solar pilot plant. Appl. Catal., B 2011, 103, (3-4), 294-301.
189. Isariebel, Q. P.; Carine, J. L.; Ulises-Javier, J. H.; Anne-Marie, W.; Henri, D., Sonolysis of levodopa and paracetamol in aqueous solutions. Ultrason. Sonochem. 2009, 16, (5), 610-616.
190. Pereira, V. J.; Weinberg, H. S.; Linden, K. G.; Singer, P. C., UV degradation kinetics and modeling of pharmaceutical compounds in laboratory grade and surface water via direct and indirect photolysis at 254 nm. Environ. Sci. Technol. 2007, 41, (5), 1682-1688.
191. Centi, G.; Perathoner, S., Use of solid catalysts in promoting water treatment and remediation technologies. In Catalysis, Spivey, J. J., Ed. The Royal Society of Chemistry: UK, 2005; Vol. 18, pp 46-68.
192. Ternes, T. A.; Stüber, J.; Herrmann, N.; McDowell, D.; Ried, A.; Kampmann, M.; Teiser, B., Ozonation: A tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res. 2003, 37, (8), 1976-1982.
193. Hoigne, J., Mechanisms, rates and selectivities of oxidations of organic compounds initiated by ozonation of water. Ann Arbor Science Publ., Ann Arbor: MI, 1982.
194. 2, UV/ozone and UV/H2O2 for treatment of fuel oxygenates MTBE, ETBE, TAME, and DIPE from water-a comparison of removal efficiencies. Water Sci. Technol. 2007, 55, (12), 307-311.
195. 2+ system and its application. J. Chem. Soc. 1884, 65, 889-899.
196. Haber, F.; Weiss, J., The catalytic decomposition of hydrogen peroxide by iron salts. J. Proc. Roy. Soc. London A 1934, 147, 332-351.
197. Tekin, H.; Bilkay, O.; Ataberk, S. S.; Balta, T. H.; Ceribasi, I. H.; Sanin, F. D.; Dilek, F. B.; Yetis, U., Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater. J. Hazard. Mat. 2006, 136, (2), 258-265.
198. Soon, A. N.; Hameed, B. H., Heterogeneous catalytic treatment of synthetic dyes in aqueous media using Fenton and photo-assisted Fenton process. Desalination 2011, 269, (1-3), 1-16.
199. Martinez, N. S. S.; Fernández, J. F.; Segura, X. F.; Ferrer, A. S., Pre-oxidation of an extremely polluted industrial wastewater by the Fenton's reagent. J. Hazard. Mat. 2003, 101, (3), 315-322.
200. Guidelines for testing of Chemicals, Simulation Test-Aerobic Sewage Treatment. In Organisation for Economic Cooperation and development (OECD), 303A, 1999.
201. Fujishima, A.; Honda, K., Electrochemical photolysis of water at a semiconductor electrode. Nature 1972, 238, 37-38.
202. Ollis, D. F.; Al-Ekabi, H., Photocatalytic purification and treatment of water and air. Elsevier: Amsterdam, 1993.
203. Pelizzetti, E.; Serpone, N., Photocatalysis: fundamental and applications. Wiley: New York, 1989.
204. Legrini, O.; Oliveros, E.; Braun, A. M., Photochemical processes for water treatment. Chem. Rev. 1993, 93, 671-698.
205. Méndez-Arriaga, F.; Esplugas, S.; Giménez, J., Photocatalytic degradation of nonsteroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation. Water Res. 2008, 42, (3), 585-594.
206. Choi, H.; Stathatos, E.; Dionysiou, D., Sol-gel preparation of mesoporous photocatalytic TiO2 films and TiO2/Al2O3 composite membranes for environmental applications. Appl. Catal., B 2006, 63, 60-67.
207. Fernández, A.; Lassaletta, G.; Jimenez, V. M.; Justo, A.; Gonzalez-Elipe, A. R.; Herrmann, J. M., Preparation and characterization of TiO2 photocatalysts supported on various rigid supports (glass, quartz and stainless steel). Comparative studies of photocatalytic activity in water purification. Appl. Catal., B 1995, 7, 49-63.
208. 2 supported on molecular sieves. Appl. Catal., B 2001, 31, 241-249.
209. Velasco, L. F.; Parra, J. B.; Ania, C. O., Role of activated carbon features on photodegradation of phenol. Appl. Surf. Sci. 2010, 256, 5254-5258.
210. Velasco, L. F.; Parra, J. B.; Ania, C. O., Phenol adsorption and photo-oxidation on porous C/Ti composites. Adsorpt. Sci. Technol. 2010, 17, 726-739.
211. Bussi, J.; Ohanian, M.; Vazquez, M.; Dalchiele, E. A., Photocatalytic removal of Hg from solid wastes of chlor-alkali plant. J. Environ. Eng. 2002, 128, (8), 733-739.
212. Eggins, B. R.; Palmer, F. L.; Byrne, J. A., Photocatalytic treatment of humic substances in drinking water. Water Res. 1997, 31, 1223-1226.
213. Mills, A.; LeHunte, S., An overview of semiconductor photocatalysis. J. Photochem. Photobiol., A 1997, 108, 1-35.
214. Shephard, G. S.; Stockenstrom, S.; de Villiers, D.; Engelbrecht, W. J.; Wessels, G. F. S., Degradation of microcystin toxins in a falling film photocatalytic reactor with immobilized titanium dioxide catalyst. Water Res. 2002, 36, 140-146.
215. Chen, G., Electrochemical technologies in wastewater treatment. Sep. Purif. Technol. 2004, 38, (1), 11-41.
216. Sirés, I.; Brillas, E., Remediation of water pollution caused by pharmaceutical residues based on electrochemical separation and degradation technologies: A review. Environ. Int. 2011, doi: 10.1016/j.envint.2011.07.012.
217. Grimm, J.; Bessarabov, D.; Sanderson, R., Review of electro-assisted methods for water purification. Desalination 1998, 115, (3), 285-294.
218. Martinez-Huitle, C. A.; Ferro, S., Electrochemical oxidation of organic pollutants for the wastewater treatment: Direct and indirect processes. Chem. Soc. Rev. 2006, 35, (12), 1324-1340.
219. 2, anodes. J. Appl. Electrochem. 1993, 23, 108-112.
220. Rajeshwar, K.; Ibanez, J. G.; Swain, G. M., Electrochemistry and the environment. J. Appl. Electrochem. 1994, 24, 1077-1091.
221. Comninellis, C., Electrochemical treatment of waste water containing phenol, Institution of Chemical Engineers Symposium Series, vol. 127. Electrochem. Eng. Environ. 1992, 92, 189-201.
222. Deshpande, A.; Lokesh, K. S.; Bejankiwar, R. S.; Gowda, T. P. H., Electrochemical oxidation of pharmaceutical effluent using cast iron electrode. J. Environ. Sci. Eng. 2005, 47, 21-24.
223. Deshpande, A. M.; Satyanarayan, S.; Ramakant, S., Electrochemical pretreatment of wastewater from bulk drug manufacturing industry. J. Environ. Eng. 2009, 135, 716-719.
224. Naddeo, V.; Belgiorno, V.; Ricco, D.; Kassinos, D., Degradation of diclofenac during sonolysis, ozonation and their simultaneous application. Ultrason. Sonochem. 2009, 16, (6), 790-794.
225. Hartmann, J.; Bartels, P.; Mau, U.; Witter, M.; Tümpling, W. V.; Hofmann, J.; Nietzschmann, E., Degradation of the drug diclofenac in water by sonolysis in presence of catalysts. Chemosphere 2008, 70, (3), 453-461.
226. Bandosz, T. J.; Ania, C. O., Surface chemistry of activated carbons and its characterization. In Activated Carbon Surfaces in Environmental Remediation, Bandosz, T. J., Ed. Elsevier: New York, 2006; Vol. 7, pp 159-229.
227. Marsh, H.; Rodríguez-Reinoso, F., Activated Carbon. Elsevier: Oxford, 2006; p 536.
228. Sing, K. S. W., Reporting physisorption data for gas/solid systems, with special reference to the determination of surface area and porosity. Pure & Appl.Chem. 1982, 54, (11), 2201-2218.
229. Ania, C. O.; Beguin, F., Mechanism of adsorption and electrosorption of bentazone on activated carbon cloth in aqueous solutions. Water Res. 2007, 41, 3372-3380.
230. Ania, C. O.; Beguin, F., Electrochemically assisted adsorption/desorption of bentazone on activated carbon cloth. Adsorption 2007, 13, 579-586.
231. Afkhami, A.; Conway, B. E., Investigation of removal of Cr(VI), Mo(VI), W(VI), V(IV), and V(V) oxy-ions from industrial wastewaters by adsorption and electrosorption at high-area carbon cloth. J. Colloid Interface Sci. 2002, 251, 248-255.
232. Ayranci, E.; Hoda, N., Adsorption of bentazone and propanil from aqueous solutions at the high area activated carbon cloth. Chemosphere 2004, 57, 755-762.
233. Przepiórski, J., Activated carbon filters and their industrial applications. In Activated Carbon Surfaces in Environmental Remediation, Bandosz, T. J., Ed. Elsevier: New York, 2006; Vol. 7, pp 421-474.
234. Karanfil, T., Activated carbon adsorption in drinking water treatment. In Activated Carbon Surfaces in Environmental Remediation, Bandosz, T. J., Ed. Elsevier: New York, 2006; Vol. 7, pp 345-374.
235. Bandosz, T. J. (Ed.), Activated Carbon Surfaces in Environmental Remediation. In Interface Science and Technology, Hubbard, A., Ed. Elsevier Ltd: UK, 2006; Vol. 7.
236. Bottani, E.; Tascón, J., Adsorption by Carbons. Elsevier Ltd: Oxford, 2008.
237. Quesada-Penate, I.; Julcour-Lebigue, C.; Jauregui-Haza, U. J.; Wilhelm, A. M.; Delmas, H., Comparative adsorption of levodopa from aqueous solution on different activated carbons. Chem. Eng. J. 2009, 152, (1), 183-188.
238. Mestre, A. S.; Pinto, M. L.; Pires, J.; Nogueira, J. M. F.; Carvalho, A. P., Effect of solution pH on the removal of clofibric acid by cork-based activated carbons. Carbon 2010, 48, (4), 972-980.
239. Mestre, A. S.; Pires, J.; Nogueira, J. M. F.; Carvalho, A. P., Activated carbons for the adsorption of ibuprofen. Carbon 2007, 45, (10), 1979-1988.
240. Mestre, A. S.; Pires, J.; Nogueira, J. M. F.; Parra, J. B.; Carvalho, A. P.; Ania, C. O., Waste-derived activated carbons for removal of ibuprofen from solution: Role of surface chemistry and pore structure. Bioresour. Technol. 2009, 100, (5), 1720-1726.
241. Ania, C. O.; Parra, J. B.; Menendez, J. A.; Pis, J. J., Microwave assisted regeneration of activated carbon loaded with pharmaceuticals. Water Res. 2007, 41, 3299-3306
242. Ania, C. O.; Parra, J. B.; Pis, J. J., Effect of texture and surface chemistry on adsorptive capacities of activated carbons for phenolic compounds removal. Fuel Process. Technol. 2002, 77-78, 337-343.
243. Ania, C. O.; Parra, J. B.; Pis, J. J., Influence of oxygen containing functional groups on active carbon adsorption of selected organic compounds. Fuel Process. Technol. 2002, 79, 265-271.
244. Nakamura, T.; Oida, Y.; Matsumoto, K.; Kawasaki, N.; Tanada, S., Inhibitory effect of sorbitol on acetaminophen adsorption by activated carbon. J. Environ. Sci. Health, Part A 2002, 37, (5), 905-912.
245. Thomas, S. H. L., Paracetamol (acetaminophen) poisoning. Pharmacol. Ther. 1993, 60, (1), 91-120.
246. Tenenbein, P. K.; Sitar, D. S.; Tenenbein, M., Interaction between N-acetylcysteine and activated charcoal: Implications for the treatment of acetaminophen poisoning. Pharmacotherapy 2001, 21, (11), 1331-1336.
247. Chamberlain, J. M.; Gorman, R. L.; Oderda, G. M.; Klein-Schwartz, W.; Klein, B. L., Use of activated charcoal in a simulated poisoning with acetaminophen: A new loading dose for N-acetylcysteine? Ann. Emerg. Med. 1993, 22, (9), 1398-1402.
248. Hoegberg, L. C. G.; Christophersen, A. B.; Christensen, H. R.; Angelo, H. R., Comparison of the adsorption capacities of an activated-charcoal-yogurt mixture versus activated-charcoal-water slurry in vivo and in vitro. Clin. Toxicol. 2005, 43, (4), 269-275.
249. Hoegberg, L. C. G.; Groenlykke, T. B.; Abildtrup, U.; Angelo, H. R., Combined paracetamol and amitriptyline adsorption to activated charcoal. Clin. Toxicol. 2010, 48, (9), 898-903.
250. Hoegberg, L. C. G.; Angelo, H. R.; Christophersen, A. B.; Christensen, H. R., The effect of food and ice cream on the adsorption capacity of paracetamol to high surface activated charcoal: In vitro studies. Pharmacol. Toxicol. 2003, 93, (5), 233-237.
251. Christophersen, A. B.; Levin, D.; Hoegberg, L. C. G.; Angelo, H. R.; Kampmann, J. P., Activated charcoal alone or after gastric lavage: A simulated large paracetamol intoxication. Br. J. Clin. Pharmacol. 2002, 53, (3), 312-317.
252. Hoegberg, L. C. G.; Angelo, H. R.; Christophersen, A. B.; Christensen, H. R., Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies. J. Toxicol.-Clin. Toxicol. 2002, 40, (1), 59-67.
253. Rutherfoord, R. S.; Gorman, R. L.; Oderda, G. M.; Klein-Schwartz, W.; Watson, W. A., Simulated acetaminophen overdose: Pharmacokinetics and effectiveness of activated charcoal. Ann. Emerg. Med. 1991, 20, (10), 1064-1068.
254. Willson, R. A.; Thompson, R. P. H.; Winch, J.; Williams, R., Rapid removal of paracetamol by hemoperfusion through coated charcoal. In-vivo and in-vitro studies in the pig. The Lancet 1973, 301, (7794), 77-79.
255. Winchester, J. F.; Edwards, R. O.; Tilstone, W. J.; Woodcock, B. G., Activated charcoal hemoperfusion and experimental acetaminophen poisoning. Toxicol. Appl. Pharmacol. 1975, 31, (1), 120-127.
256. Cabrita, I.; Ruiz, B.; Mestre, A. S.; Fonseca, I. M.; Carvalho, A. P.; Ania, C. O., Removal of an analgesic using activated carbons prepared from urban and industrial residues. Chem. Eng. J. 2010, 163, (3), 249-255.
257. Mestre, A. S.; Bexiga, A. S.; Proença, M.; Andrade, M.; Pinto, M. L.; Matos, I.; Fonseca, I. M.; Carvalho, A. P., Activated carbons from sisal waste by chemical activation with K2CO3: Kinetics of paracetamol and ibuprofen removal from aqueous solution. Bioresour. Technol. 2011, 102, (17), 8253-8260.
258. Ruiz, B.; Cabrita, I.; Mestre, A. S.; Parra, J. B.; Pires, J.; Carvalho, A. P.; Ania, C. O., Surface heterogeneity effects of activated carbons on the kinetics of paracetamol removal from aqueous solution. Appl. Surf. Sci. 2010, 256, (17), 5171-5175.
259. Cotoruelo, L. M.; Marques, M. D.; Leiva, A.; Rodriguez-Mirasol, J.; Cordero, T., Adsorption of oxygen-containing aromatics used in petrochemical, pharmaceutical and food industries by means of lignin based active carbons. Adsorption 2011, 17, (3), 539-550.
260. Roskill Report, The Economics of Activated Carbon, 6th ed. Roskill Information Services Ltd; Claphham Road, London, 1998.
261. Terzyk, A. P., Describing adsorption of paracetamol from aqueous solution on carbons while utilizing the most widespread isotherm models-the impact of surface carbonyl and basic groups. J. Colloid Interface Sci. 2002, 247, (2), 507-510.
262. Beninati, S.; Semeraro, D.; Mastragostino, M., Adsorption of paracetamol and acetylsalicylic acid onto commercial activated carbons. Adsorpt. Sci. Technol. 2008, 26, (9), 721-734.
263. Wisniewski, M.; Pacholczyk, A.; Terzyk, A. P.; Rychlicki, G., New phosphorus-containing spherical carbon adsorbents as promising materials in drug adsorption and release. J. Colloid Interface Sci. 2011, 354, (2), 891-894.
264. Terzyk, A. P., The influence of activated carbon surface chemical composition on the adsorption of acetaminophen (paracetamol) in vitro: Part II. TG, FTIR, and XPS analysis of carbons and the temperature dependence of adsorption kinetics at the neutral pH. Colloids Surf., A 2001, 177, (1), 23-45.
265. Terzyk, A. P., Adsorption of biologically active compounds from aqueous solutions on to commercial unmodified activated carbons. Part IV. Do the properties of amphoteric carbon surface layers influence the adsorption of paracetamol at acidic pH levels? Adsorpt. Sci. Technol. 2003, 21, (1), 93-123.
266. Terzyk, A. P., Adsorption of biologically active compounds from aqueous solutions on to commercial unmodified activated carbons. Part III. Theoretical description of paracetamol adsorption data at neutral pH. Adsorpt. Sci. Technol. 2002, 20, (1), 63-81.
267. Terzyk, A. P., The impact of carbon surface composition on the diffusion and adsorption of paracetamol at different temperatures and at neutral pH. J. Colloid Interface Sci. 2000, 230, (1), 219-222.
268. Terzyk, A. P., Adsorption of biologically active compounds from aqueous solutions on to commercial unmodified activated carbons. Part II. Temperature dependence of adsorption kinetics of 4-hydroxyacetanilide (paracetamol) at neutral pH. Adsorpt. Sci. Technol. 2000, 18, (5), 477-508.
269. Terzyk, A. P., Molecular properties and intermolecular forces-factors balancing the effect of carbon surface chemistry in adsorption of organics from dilute aqueous solutions. J. Colloid Interface Sci. 2004, 275, (1), 9-29.
270. Terzyk, A. P.; Cwiertnia, M. S.; Wisniewski, M.; Gauden, P. A.; Rychlicki, G.; Szymanski, G. S., Impact of the interaction with the positive charge in adsorption of benzene and other organic compounds from aqueous solutions on carbons. Appl. Surf. Sci. 2007, 253, (8), 4006-4009.
271. Terzyk, A. P.; Rychlicki, G., The influence of activated carbon surface chemical composition on the adsorption of acetaminophen (paracetamol) in vitro: The temperature dependence of adsorption at the neutral pH. Colloids Surf., A 2000, 163, (2-3), 135-150.
272. Terzyk, A. P.; Rychlicki, G.; Biniak, S.; Lukaszewicz, J. P., New correlations between the composition of the surface layer of carbon and its physicochemical properties exposed while paracetamol is adsorbed at different temperatures and pH. J. Colloid Interface Sci. 2003, 257, (1), 13-30.
273. Villaescusa, I.; Fiol, N.; Poch, J.; Bianchi, A.; Bazzicalupi, C., Mechanism of paracetamol removal by vegetable wastes: The contribution of Jillaescusa, L; Fiol, N.; bonding and hydrophobic effect. Desalination 2011, 270, (1-3), 135-142.
274. Bekçi, Z.; Seki, Y.; Kadir Yurdakoç, M., A study of equilibrium and FTIR, SEM/EDS analysis of trimethoprim adsorption onto K10. J. Mol. Struct. 2007, 827, (1-3), 67-74.
275. Bekçi, Z.; Seki, Y.; Yurdakoç, M. K., Equilibrium studies for trimethoprim adsorption on montmorillonite KSF. J. Hazard. Mat. 2006, 133, (1-3), 233-242.
276. Gereli, G.; Seki, Y.; Murat Kusoglu, I.; Yurdakoç, K., Equilibrium and kinetics for the sorption of promethazine hydrochloride onto K10 montmorillonite. J. Colloid Interface Sci. 2006, 299, (1), 155-162.
277. Bajpai, A. K.; Rajpoot, M.; Mishra, D. D., Studies on the correlation between structure and adsorption of sulfonamide compounds. Colloids Surf., A 2000, 168, (3), 193-205.
278. Lorphensri, O.; Intravijit, J.; Sabatini, D. A.; Kibbey, T. C. G.; Osathaphan, K.; Saiwan, C., Sorption of acetaminophen, 17 alpha-ethynyl estradiol, nalidixic acid, and norfloxacin to silica, alumina, and a hydrophobic medium. Water Res. 2006, 40, (7), 1481-1491.
279. Xiao, P.; Dudal, Y.; Corvini, P. F. X.; Shahgaldian, P., Polymeric cyclodextrin-based nanoparticles: synthesis, characterization and sorption properties of three selected pharmaceutically active ingredients. Polym. Chem. 2011, 2, (1), 120-125.